Main Article Content

Abstract

Coronavirus is a common type of virus that usually infects humans and results in a high breathing infection. This virus transmits through the air by coughing and sneezing, near physical contacts, and touching virus-contaminated substances or surfaces. Symptoms include runny nose, sore throat, feeling unwell, cough, and fever. The coronavirus outbreak (officially known as COVID-19), which started in China, has so far taken lives of over 190,656 people and affected 2,718,797 people across the world. The infection has spread to 185 countries. According to the official report released by the Ministry of Health and Family Welfare of the Union (MoHFW), 23,077 confirmed cases and 718 deaths have been registered so far in India. The transmission of COVID-19 was successfully controlled by India until now. The Department of Indian Health Science is well organized to control the corona epidemic. The Indian Health Sciences Department and the Regulatory Team (CDSCO) are advancing bio-war against the pandemic by providing effective and constructive updates to the pharmaceutical industry and making it easier for the citizens to prevent transmission in India. The most critical factor in preventing the local spread of the virus is to motivate the public to obtain the right information and take precautions in compliance with the health ministry's warnings.

Keywords

COVID - 19 Pandemic Bio-war CDSCO Regulatory framework

Article Details

How to Cite
Beula Evangeline C, & Ganesh GNK. (2020). India’s Bio-War against a Pandemic Threat COVID-19. International Journal of Research in Pharmaceutical Sciences, 11(SPL1), 913-917. https://doi.org/10.26452/ijrps.v11iSPL1.3130